MedPal AI Plc
LLSE:MPAL4.60
GBX
-0.35
(-7.07%)
ISIN
GB00BTRC7N37
Return %
Stock
S&P 500
1Y
-47.43
14.20
3Y
- -
81.12
5Y
- -
68.34
Capital Structure
GBP
•
in mil. unless spec.Working Capital
GBP
•
in mil. unless spec.Growth Rates
GBP
•
in mil. unless spec.Semi-annual Revenue
GBP
•
in mil. unless spec.Semi-annual Earnings Per Share
GBP
•
in mil. unless spec.Semi-annual Dividends Per Share
GBP
•
in mil. unless spec.Company Description
- CEO
- Jason Kingsley Drummond
- Full Time Employees
- 5
- Sector
- Technology services
- Industry
- Packaged software
- Address
- 71 Queen Victoria Street London GL United Kingdom EC4V 4AY
- IPO Date
- Aug 26, 2025
- Website
- medpal.ai
- Similar Companies
- Business
- MedPal AI Plc operates as a technology-driven healthcare information company delivering AI-assisted medical data and decision-support solutions. The firm focuses on enabling clinicians, payers, researchers, and life sciences companies to access, analyze, and act on clinical and operational data through advanced analytics, machine learning models, and integrated platforms. Main Products and Services: AI-driven clinical decision support systems; AI-powered medical data platforms; natural language processing and transcription services for clinical documentation; population health analytics; risk stratification and predictive modeling; workflow automation and care-management solutions; data integration and interoperability tooling (HL7 FHIR interfaces, API access); data curation, normalization, and quality assurance; customizable dashboards and visualization tools; regulatory-compliant data governance and privacy solutions; secure cloud-hosted data repositories; professional services including implementation, integration, training, and ongoing support; healthcare reimbursement and coding analytics; research-grade data access for clinical trials and real-world evidence; software as a service subscriptions with tiered feature sets; on-premises deployment options for large-scale institutions; multi-tenant and single-tenant deployment models; security and compliance offerings (HIPAA, GDPR alignment, SOC 2). Latest Major Company Changes: Forms strategic alliances with healthcare providers and technology platforms to broaden data sources and deployment footprints; completes funding rounds supporting product expansion and regional market entries; launches new AI modules for real-time clinical risk scoring and patient engagement; expands geographic footprint into Europe and Asia-Pacific; undergoes branding or corporate reorganizations to reflect expanded capabilities; reports major operational scale improvements including added data centers and enhanced data security infrastructure within the last 1-2 years. Additional Context: Industry and segments include healthcare IT, health analytics, and AI-enabled clinical informatics; serves hospitals, health systems, private and public payers, pharmaceutical and life sciences firms, and research institutes; target customers include CIOs, CMIOs, clinical leaders, risk managers, and researchers; geographic operations span multiple regions including North America, Europe, and Asia-Pacific; founding year and headquarters location are part of the company profile; potential subsidiaries or parent relationships reflect corporate structure and group affiliations.